• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性非息肉病性结直肠癌(HNPCC)综合征中不同癌症的终生风险。

Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.

作者信息

Aarnio M, Mecklin J P, Aaltonen L A, Nyström-Lahti M, Järvinen H J

机构信息

Second Department of Surgery, Helsinki University Central Hospital, Finland.

出版信息

Int J Cancer. 1995 Dec 20;64(6):430-3. doi: 10.1002/ijc.2910640613.

DOI:10.1002/ijc.2910640613
PMID:8550246
Abstract

Identification of hereditary non-polyposis colorectal cancer (HNPCC) indicates theoretical life-time risks of 50% for the descendants of an affected family member and of 100% for the true gene carriers. However, besides colorectal cancer (CRC), many other cancer types and sites are also involved, which gives reason to evaluate the magnitude of risk for various other cancer types. A detailed pedigree analysis of 40 families with HNPCC identified 414 patients affected with cancer. A Kaplan-Meier life-table analysis for the cumulative risk of various cancers was performed on the basis of the 293 putative gene carriers who had adequate clinical and histological documentation of their tumors. Cumulative risks were highest for colorectal (78%) and endometrial cancers (43%, women only), followed by gastric, biliary tract, urinary tract and ovarian cancers (19-9%). For the other probably HNPCC-related cancer types, such as small bowel carcinoma and brain tumors, the life-time risk was only 1%. The risk of any metachronous cancer reached 90% after treatment of CRC and 75% after endometrial cancer; the second tumor was most often a new CRC or endometrial cancer. CRC remains the most important cancer type in the HNPCC syndrome but does not develop in all gene carriers. This makes the decision of possible prophylactic colectomy for test-detected gene carriers difficult. Of the many other cancer types involved, at least endometrial cancer is common enough to necessitate a specific surveillance program.

摘要

遗传性非息肉病性结直肠癌(HNPCC)的确诊表明,受影响家庭成员的后代理论上终生患癌风险为50%,而真正的基因携带者终生患癌风险为100%。然而,除了结直肠癌(CRC)外,许多其他癌症类型和部位也会受累,这就需要评估其他各种癌症类型的风险程度。对40个HNPCC家庭进行的详细系谱分析确定了414名癌症患者。基于293名有充分肿瘤临床和组织学记录的推定基因携带者,对各种癌症的累积风险进行了Kaplan-Meier生存表分析。结直肠癌(78%)和子宫内膜癌(仅女性为43%)的累积风险最高,其次是胃癌、胆管癌、泌尿系统癌和卵巢癌(19%-9%)。对于其他可能与HNPCC相关的癌症类型,如小肠癌和脑肿瘤,终生风险仅为1%。结直肠癌治疗后异时性癌症风险达到90%,子宫内膜癌治疗后为75%;第二种肿瘤最常见的是新发结直肠癌或子宫内膜癌。结直肠癌仍然是HNPCC综合征中最重要的癌症类型,但并非所有基因携带者都会患结直肠癌。这使得对于检测出基因携带者是否进行预防性结肠切除术的决策变得困难。在涉及的许多其他癌症类型中,至少子宫内膜癌足够常见,需要制定特定的监测方案。

相似文献

1
Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome.遗传性非息肉病性结直肠癌(HNPCC)综合征中不同癌症的终生风险。
Int J Cancer. 1995 Dec 20;64(6):430-3. doi: 10.1002/ijc.2910640613.
2
Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.巴西遗传性非息肉病性结直肠癌(HNPCC)和家族性结直肠癌(FCC)家庭中结肠外肿瘤的发生率:巴西遗传性结直肠癌机构登记处的分析。
Fam Cancer. 2004;3(1):41-7. doi: 10.1023/B:FAME.0000026810.99776.e9.
3
[Hereditary colorectal cancer].[遗传性结直肠癌]
Korean J Gastroenterol. 2005 Feb;45(2):78-87.
4
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
5
Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.家族性腺瘤性息肉病(FAP)与遗传性非息肉病性结直肠癌(HNPCC):临床、遗传及治疗方面的综述
Schweiz Med Wochenschr. 1997 Apr 19;127(16):682-90.
6
Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.通过对结直肠癌和子宫内膜癌肿瘤进行分子分析来鉴定遗传性非息肉病性结直肠癌。
Dis Markers. 2004;20(4-5):207-13. doi: 10.1155/2004/391039.
7
[Genetics of colorectal cancer. I. Non-polyposis and polyposis forms of hereditary colorectal cancer].[结直肠癌的遗传学。I. 遗传性结直肠癌的非息肉病型和息肉病型]
Ned Tijdschr Geneeskd. 1999 Jun 5;143(23):1201-6.
8
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.遗传性非息肉病性结直肠癌:诊断策略及其影响。
Evid Rep Technol Assess (Full Rep). 2007 May(150):1-180.
9
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.林奇综合征及林奇综合征模拟病症:遗传性结肠癌日益复杂的格局。
World J Gastroenterol. 2015 Aug 21;21(31):9253-61. doi: 10.3748/wjg.v21.i31.9253.
10
[Hereditary colorectal cancer].[遗传性结直肠癌]
Chirurg. 2008 Nov;79(11):1038-46. doi: 10.1007/s00104-008-1557-z.

引用本文的文献

1
The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression.DNA错配修复蛋白MSH6是程序性死亡受体配体1(PD-L1)表达的新型调节因子。
Neoplasia. 2025 Sep;67:101207. doi: 10.1016/j.neo.2025.101207. Epub 2025 Jul 11.
2
Second malignancies in patients with deficient mismatch repair system/microsatellite instability-high colorectal cancer.错配修复缺陷系统/微卫星高度不稳定型结直肠癌患者的第二原发性恶性肿瘤
Therap Adv Gastroenterol. 2025 Jun 21;18:17562848251347375. doi: 10.1177/17562848251347375. eCollection 2025.
3
Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors.
实体瘤中的错配修复缺陷与微卫星不稳定性
Int J Mol Sci. 2025 May 6;26(9):4394. doi: 10.3390/ijms26094394.
4
Predicting Survival Among Colorectal Cancer Patients: Development and Validation of Polygenic Survival Score.预测结直肠癌患者的生存率:多基因生存评分的开发与验证
Clin Exp Gastroenterol. 2024 Oct 14;17:317-329. doi: 10.2147/CEG.S464324. eCollection 2024.
5
Lynch syndrome-associated and sporadic microsatellite unstable colorectal cancers: different patterns of clonal evolution yield highly similar tumours.林奇综合征相关与散发性微卫星不稳定结直肠癌:不同的克隆进化模式产生高度相似的肿瘤。
Hum Mol Genet. 2024 Nov 5;33(21):1858-1872. doi: 10.1093/hmg/ddae124.
6
Perception about benefits and risks related to combined hormonal contraceptives use in women with Lynch syndrome.林奇综合征女性使用复方激素避孕药相关益处和风险的认知。
Ann Med. 2024 Dec;56(1):2370568. doi: 10.1080/07853890.2024.2370568. Epub 2024 Jun 26.
7
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.家族史在预测发生胰腺癌的种系致病性变异携带者中的作用:一项多中心合作的研究结果。
Cancer. 2024 Oct 1;130(19):3297-3304. doi: 10.1002/cncr.35383. Epub 2024 May 29.
8
Synchronous gastric and colon cancers: Important to consider hereditary syndromes and chronic inflammatory disease associations.同步性胃癌和结肠癌:考虑遗传性综合征及慢性炎症性疾病关联很重要。
World J Gastrointest Oncol. 2024 Mar 15;16(3):571-576. doi: 10.4251/wjgo.v16.i3.571.
9
A comprehensive analysis of immunotherapy in advanced endometrial cancer (Review).晚期子宫内膜癌免疫治疗的综合分析(综述)
Oncol Lett. 2023 Dec 28;27(2):77. doi: 10.3892/ol.2023.14210. eCollection 2024 Feb.
10
Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients.比较高危子宫内膜癌和结直肠癌患者中林奇综合征检测的直接种系测序和多步筛查。
J Gynecol Oncol. 2024 Jan;35(1):e5. doi: 10.3802/jgo.2024.35.e5. Epub 2023 Sep 5.